供应商货号
CAS号
HIT ID
供应商货号
SMILES
化合物库
zh
购物车
0
首页
化合物检索
结构搜索
采用结构式进行搜索
批量检索
采用批量进行搜索
定制合成
定制合成化合物
活性分子与生物试剂
抑制剂&激动剂
天然产物
ADC 相关
多肽
PROTAC
染料
分子与细胞研究试剂
疾病造模
化合物服务
样品定制分装
提供样品分装服务
活性测试液配制
专业的定制溶液服务
独立质控服务
专门的化合物质量检测
国际物流清关
省心省力送到您手上
化合物共享平台
闲置化合物转起来
化合物库
活性化合物库
通用已知活性库
上市状态分类
疾病类型分类
通路靶点分类
特色活性库
天然产物库
高通量筛选天然产物库
特色天然产物库
天然产物衍生物库
中医药天然产物库
结构分类天然产物库
疾病功能天然产物库
类药性化合物库
高通量/高内涵化合物库
按潜在疾病分类
按潜在通路靶点分类
特色多样性化合物库
Fragment片段库
通用片段库
特色片段库
NMR和晶体片段库
共价片段库
技术服务
活性筛选
抗肿瘤药物体外筛选
核受体靶点筛选
酶学靶点活性
计算机辅助药物设计
靶点结构模拟与预测
虚拟筛选/分子对接
人工智能药物设计
靶点鉴定
化合物库定制
Topscience Database
筛选化合物数据库
药物筛选的重要基础
L1000W数据库
让研究更高效
大环化合物数据库
均衡的复杂性和高度新颖性
共价化合物数据库
提供多种规格和包装选项
天然产物数据库
化合物结构提供SDF格式文件
片段化合物数据库
适用于不同疾病领域的研究
活性化合物数据库
提供了丰富的化学结构多样性
分子胶化合物数据库
分子胶抑制剂研究的有力工具
关于我们
关于我们
联系我们
我们的供应商
成为供应商
供应商货号
CAS号
HIT ID
供应商货号
SMILES
化合物库
Others
Advanced Glycation End Products
CYP19A1
Decarboxylase
DprE1
Fer/FerT kinase
Platelet aggregation
Progesterone Receptor
Others
信号通路
其他
Others
Others
Targetmol为生命科学及医药领域的科研人员提供其他未细分细胞信号通路相关产品,包括抑制剂、激动剂、调节剂、降解剂等。
HIT218963912
BDZ-h
T70501
1516903-65-3
BDZ-h is a potent inhibitor of both the closed-channel and the open-channel conformations of all four homomeric AMPA receptor channels and two GluA2R containing complex AMPA receptor channels.
Others
HIT218964162
D-Ribofuranose1-dihydrogenphosphate dicyclohexanamine
T74046
58459-37-3
D-Ribofuranose1-dihydrogenphosphate dicyclohexanamine,即1-磷酸核糖,作为核苷酸合成的关键中间体,在5-氟尿嘧啶(FUra)的磷酸化过程中,被尿苷磷酸化酶催化转化为核苷。
Endogenous Metabolite
Others
HIT220912985
AH 23848
T68650
81443-73-4
AH 23848 is a Thromboxane antagonist which accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells.
Others
HIT218433002
Pemetrexed Diethyl Ester
T70583
146943-43-3
Pemetrexed Diethyl Ester is a protected intermediate in the synthesis of Pemetrexed, a multi-targeted anti-folate that inhibits thymidylate synthase as well as other folate dependent enzymes.
Others
HIT220912154
DN 9693
T68222
96086-68-9
DN 9693 is a potent inhibitor of platelet aggregation.
Others
HIT219453149
PCC0208018
T70291
1673534-73-0
PCC0208018 is a novel activator of effector T cells, enhancing T cell proliferation and activation to release interferon gamma (IFN-γ) and interleukin-2 (IL-2) without blocking the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) binding and not directly affecting tumor cell viability in vitro.
Others
HIT220913558
KAA-276 HCl
T70293
167264-26-8
KAA-276 HCl is the salt form of KAA-276 free base, a novel potent and long-lasting histamine HI-receptor antagonist with less-topical irritation, and can be topically administered by inhalation for the treatment of bronchial asthma.
Others
HIT219465066
AFN941
T69812
220038-19-7
AFN941 is a staurosporine analog, acting as a Jak3-specific inhibitor.
EGFR
JAK
Others
HIT219469122
AZD-1386
T68281
942937-80-6
AZD1386 is an orally available antagonist of the transient receptor potential channel TRPV1. Note: Structure of this product was from NIH/NCATS web page: https://drugs.ncats.io/drug/210323T9CP and drugbank web page: https://go.drugbank.com/drugs/DB15333.
Others
HIT220913674
Cidofovir sodium
T71066
127749-27-3
Cidofovir sodium is the salt form of Cidofovir, a Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor that is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis in people with AIDS. The mechanism of action of cidofovir is as a DNA Polymerase Inhibitor. The chemical classification of cidofovir anhydrous is Nucleoside Analog.
Apoptosis
DNA/RNA Synthesis
Endogenous Metabolite
Others
Virus Protease
HIT218963856
SHR0687
T69850
2168573-03-1
SHR0687 is a Highly Potent KOR Agonist. SHR0687 showed excellent selectivity over other opioid receptors, such as MOR and DOR. In addition, SHR0687 displayed favorable PK profiles across species, as well as robust in vivo efficacy in a rat carrageenan-induced pain model. Notably, SHR0687 exhibited negligible blood−brain barrier penetration, which was meaningful in minimizing CNS-related side effects.
Others
HIT218963664
HPI-1 (hydrate)
T35538
1262770-72-8
HPI-1 (hydrate) is a Hedgehog (Hh) pathway inhibitor that suppresses signaling through Sonic Hh (IC50= 1.5 μM) without significantly affecting Wnt signaling (IC50≥ 30 μM).1HPI-1 suppresses Hh activation induced by loss of Suppressor of Fused or by Gli overexpression, suggesting action at posttranslational modification of Gli protein or at the interaction of Gli with a co-factor.1HPI-1 (hydrate) also inhibits signaling through the oncogenic Smoothened (Smo) mutant SmoM2 in neuron precursors, preventing cell proliferation.1 1.Hyman, J.M., Firestone, A.J., Heine, V.M., et al.Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockadeProceedings of the National Academy of Sciences of the United States of America106(33)14132-14137(2009)
Others
HIT219450352
Arnolol
T68478
87129-71-3
Arnolol is a beta blocker. Beta blockers block the hormone epinephrine, also known as adrenaline. This causes the heart to beat more slowly and with less force, thereby reducing blood pressure. Beta blockers also help blood vessels open up to improve blood flow.
Adrenergic Receptor
Others
HIT220912837
Proteasome-IN-3
T71092
1262295-74-8
Proteasome-IN-3 is an inhibitor of proteasome-associated DUBs.
Others
HIT218963855
NCI-006
T70032
1964516-64-0
NCI-006 is a potent new inhibitor of lactate dehydrogenase (LDH) that disrupts tumor growth in mice. LDH inhibition slows tumor growth but rapidly redirects pyruvate to support mitochondrial metabolism. Inhibiting both mitochondrial complex 1 and LDH suppresses metabolic plasticity of glycolytic tumors in vivo, significantly prolonging tumor growth inhibition.
Apoptosis
Dehydrogenase
Others
ROS
HIT220913301
ZEL-H16
T71270
1195834-86-6
ZEL-H16 is an agonist of the histamine H3 receptor.
Others
HIT220913363
Enecadin HCl
T70199
178429-67-9
Enecadin HCl is a voltage-dependent sodium and calcium channel blocker.
Endogenous Metabolite
Others
HIT218963780
Flusoxolol
T68596
84057-96-5
Flusoxolol is a beta-adrenoceptor partial agonist.
Others
HIT219469171
MS47134
T73433
MS47134是一种MRGPRX4激动剂,具有高效性和选择性,其EC50为149 nM。该化合物可应用于疼痛、瘙痒以及肥大细胞介导的超敏反应研究。
MRGPR
Others
HIT220913333
MSD-D
T70139
182504-18-3
MSD-D is an inhibitor of voltage-gated K(+) (Kv) channels Kv1.5.
Others
Potassium Channel
HIT220913219
SPR519
T70792
1391923-59-3
SPR519 is a potent dual inhibitor of PI3Kα and mTOR kinases with IC50 (PI3Kalpha) = 30 nM and IC50 (mTOR) = 10 nM. SPR519 exhibits an EC50 of low sub-micromolar range among various tested cancer cell lines such as A2780 (0.23 μM), PC3 (0.48 μM), and SKOV3 (0.50 μM).
Others
HIT218963999
Monorden diacetate
T71645
100262-15-5
Monorden diacetate a Hsp90 Inhibitor. Monorden diacetate is a Promising Lead Compound for the Development of Novel Fungicides.
HSP
Others
HIT217662356
Olmesartan ethyl ester
T73974
144689-23-6
Olmesartan ethyl ester (compound 11) 是 Olmesartan 的一个杂质。Olmesartan (RNH-6270) 是血管紧张素 II 受体 (AT1R) 拮抗剂,可用于高血压研究。
Drug Metabolite
Others
HIT220913624
Pipoxolan hydrochloride
T70153
18174-58-8
Pipoxolan (HCl) is an antispasmodic drug. In vivo, the drug inhibited the contractions of intestines caused by neostigmine, barium chloride or injection of acetylcholine. The drug possesses ganglioplegic action and inhibited the decrease in blood pressure caused by stimulation of the vagus nerve. The drug is marketed under tradename Rowapraxin worldwide for the treatment of spasms and colics in the gastrointestinal tract, gallbladder and urogenital area, bronchial spasms, spastic menstrual cramps. Recent studies have shown that pipoxalan has anticancer activity and inhibits proliferation of leukemia cells in animal models.
Others
HIT218964190
(Rac)-POPC
T74242
26662-91-9
(Rac)-POPC 是制备巨囊泡 (GV) 的模型磷脂。
Liposome
Others
HIT220912103
AZD-1175
T68515
863639-43-4
AZD-1175 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for the treatment of type 2 diabetes and obesity.
Others
HIT220913283
ELND007
T70635
1444006-79-4
ELND007 is a Gamma secretase inhibitor.
Beta Amyloid
Gamma-secretase
Others
HIT220913117
NVP-BHS345
T70182
1798292-13-3
NVP-BHS345 is a dual inhibitor of TORC1 and TORC2.
Others
HIT218963955
MDL-43291
T71043
129357-91-1
MDL-43291 is a leukotriene receptor antagonist.
Others
HIT220912741
Trimetaphan camsilate
T68811
7187-66-8
Trimetaphan camsilate is a drug that counteracts cholinergic transmission at the ganglion type of nicotinic receptors of the autonomic ganglia and therefore blocks both the sympathetic nervous system and the parasympathetic nervous system. It acts as a non-depolarizing competitive antagonist at the nicotinic acetylcholine receptor, is short-acting, and is given intravenously.
Others
HIT219442057
cis-Entacapone
T70608
145195-63-7
cis-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor entacapone. It is also a potential impurity found in commercial preparations of entacapone and a degradant of entacapone formed by UV light exposure.
Others
Transferase
HIT218833090
N-Nitrosoglyphosate sodium
T74078
56516-71-3
N-Nitrosoglyphosate sodium 是亚硝胺的降解产物,是草甘膦除草剂的合成杂质。
Drug Metabolite
Others
HIT218886700
trans-Miyabenol C
T71452
109605-83-6
trans-Miyabenol C is a natural resveratrol trimer, acting as a protein kinase C inhibitor.
Others
HIT220913254
Noberastine citrate
T70773
139751-07-8
Noberastine citrate, a histamine H1 antagonist, has potent and specific peripheral antihistaminic activity. Noberastine, a furan derivative of nor-astemizole (an astemizole metabolite), has been shown to have a more rapid onset, and shorter duration of action than astemizole with peak antihistaminic activity at 4h following ingestion. Noberastine is rapidly absorbed and the peak plasma levels are obtained within 2 h of oral dosing. In preclinical studies Noberastine has been shown to lack central nervous system effects. After subacute (steady-state) administration of noberastine, there was increasing inhibition of weal and flare formation with higher doses of the drug. The 30 mg daily dose showed maximum antihistaminic effects.
Others
HIT220913264
OD38
T70327
1638644-63-9
OD38 is a novel potent and selective receptor-interacting protein kinase 2 (ripk2) inhibitor
Others
HIT218963979
G-479
T71344
1168092-22-5
G-479 is an potent MEK inhibitor. Structurally, G-479 is an analogue of GDC-0623 (or so-call Me-Too drug). G-479 with polarity distributed throughout the molecule was shown improved bioactivity over GDC-0623 in many aspects.
MEK
Others
Potassium Channel
/ 278 页
上一页
1
...
134
135
136
...
278
下一页
正在加载 ~
常用功能
使用指南
化合物搜索
在线客服
返回顶层